Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0191 | 0.6299 | 0.7633 |
Brugia malayi | RNA binding protein | 0.0191 | 0.6299 | 0.7633 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.01 | 0.2414 | 0.2925 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.1063 | 0.1688 |
Brugia malayi | MH2 domain containing protein | 0.0237 | 0.8252 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6299 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6299 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0191 | 0.6299 | 0.7633 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0191 | 0.6299 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0191 | 0.6299 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6299 | 1 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0 | 0.5 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.1063 | 0.1288 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0237 | 0.8252 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6299 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0237 | 0.8252 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.2414 | 0.2925 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0191 | 0.6299 | 0.7633 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6299 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0191 | 0.6299 | 0.7633 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0191 | 0.6299 | 0.7633 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.1063 | 0.1288 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.01 | 0.2414 | 0.2925 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.01 | 0.2414 | 0.2925 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.